首页 | 本学科首页   官方微博 | 高级检索  
检索        

三联疗法与胃炎灵联合治疗胃溃疡幽门螺旋杆菌感染60例的临床研究
引用本文:谭昊.三联疗法与胃炎灵联合治疗胃溃疡幽门螺旋杆菌感染60例的临床研究[J].医疗保健器具,2014(12):1579-1580.
作者姓名:谭昊
作者单位:湖南省郴州市第四人民医院,湖南郴州423000
摘    要:目的 探讨三联疗法与胃炎灵联合治疗胃溃疡幽门螺旋杆菌感染的临床疗效.方法 选取我院2010年2月至2014年1月期间收治的120例幽门螺旋杆菌感染胃溃疡患者为研究对象,将其随机分为观察组和对照组,每组各60例.对照组采用雷贝拉唑+阿莫西林+克拉霉素三联疗法治疗,观察组在对照组基础上加用胃炎灵治疗.比较两组患者治疗总有效率、幽门螺旋杆菌根除率及胃溃疡复发率.结果 观察组治疗总有效率高达96.7%,对照组为86.7%,两组比较差异具有统计学意义(P<0.05);观察组治疗后幽门螺旋杆菌根除率为93.3%,对照组为80.0%,两组比较差异具有统计学意义(P<0.05);观察组治疗后胃溃疡复发率为3.3%,对照组为15.0%,两组比较差异具有统计学意义(P<0.05).结论 三联疗法联合胃炎灵治疗胃溃疡幽门螺旋杆菌感染效果较好,可有效提高幽门螺旋杆菌根除率,安全可靠,不良反应少.

关 键 词:胃炎灵  胃溃疡  幽门螺旋杆菌  雷贝拉唑

Clinical Research on Triple Therapy Combined with Weiyanling in the Treatment of Helicobacter Pylori Infection in Gastric Ulcer with 60 Cases
TAN Hao.Clinical Research on Triple Therapy Combined with Weiyanling in the Treatment of Helicobacter Pylori Infection in Gastric Ulcer with 60 Cases[J].Medicine Healthcare Apparatus,2014(12):1579-1580.
Authors:TAN Hao
Institution:TAN Hao (The Fourth People 's Hospital of Chenzhou, Chenzhou 423000, China)
Abstract:Objective To investigate the clinical effect of triple therapy combined with Weiyanling in the treatment of Helicobacter pylori infection in gastric ulcer. Methods 120 cases of patients with gastric ulcer and Helieobaeter pylori infection treated in our hospital from February 2010 to January 2014 were selected as objects and randomly divided into observation group and control group, with 60 cases in each group. The control group was treated with triple therapy with rabeprazole sodium + amoxicillin + clarithromycin, while the observation group was treated with Weiyanling on the basis of the control group. The total effective rate, eradication of Helieobaeter pylori and gastric ulcer recurrence rate of the two groups were compared. Results The total effective rate of the observation group was 96.7%, significantly higher than 86.7% of the control group, with statistical difference (P 〈0.05); the eradication rate of Helicobaeter pylori of the observation group was 93.3%, significantly higher than 80% of the control group, with statistical significant difference (P〈0.05); the gastric ulcer recurrence rate of the observation group was 3.3%, significantly lower than 15% of the control group, with statistical significant difference (P 〈0.05). Conclusions The application of triple therapy combined with Weiyanling has good effect in the treatment of Helieobaeter pylori infection in gastric ulcer and effectively improves the eradication rate of Helicobaeter pylori, with high safety and fewer adverse reactions.
Keywords:Weiyanling  Gastric ulcer  Helicobacter pylori  Rabeprazole
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号